These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 12446621)

  • 1. Role of ghrelin in streptozotocin-induced diabetic hyperphagia.
    Ishii S; Kamegai J; Tamura H; Shimizu T; Sugihara H; Oikawa S
    Endocrinology; 2002 Dec; 143(12):4934-7. PubMed ID: 12446621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypothalamic neuropeptide Y/Y1 receptor pathway activated by a reduction in circulating leptin, but not by an increase in circulating ghrelin, contributes to hyperphagia associated with triiodothyronine-induced thyrotoxicosis.
    Ishii S; Kamegai J; Tamura H; Shimizu T; Sugihara H; Oikawa S
    Neuroendocrinology; 2003 Dec; 78(6):321-30. PubMed ID: 14688445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of endogenous ghrelin in the hyperphagia of mice with streptozotocin-induced diabetes.
    Dong J; Peeters TL; De Smet B; Moechars D; Delporte C; Vanden Berghe P; Coulie B; Tang M; Depoortere I
    Endocrinology; 2006 Jun; 147(6):2634-42. PubMed ID: 16484325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of streptozotocin-induced diabetes and insulin treatment on the hypothalamic melanocortin system and muscle uncoupling protein 3 expression in rats.
    Havel PJ; Hahn TM; Sindelar DK; Baskin DG; Dallman MF; Weigle DS; Schwartz MW
    Diabetes; 2000 Feb; 49(2):244-52. PubMed ID: 10868941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression analysis of hypothalamic and pituitary components of the growth hormone axis in fasted and streptozotocin-treated neuropeptide Y (NPY)-intact (NPY+/+) and NPY-knockout (NPY-/-) mice.
    Park S; Peng XD; Frohman LA; Kineman RD
    Neuroendocrinology; 2005; 81(6):360-71. PubMed ID: 16244497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation of diabetic hyperphagia in neuropeptide Y--deficient mice.
    Sindelar DK; Mystkowski P; Marsh DJ; Palmiter RD; Schwartz MW
    Diabetes; 2002 Mar; 51(3):778-83. PubMed ID: 11872679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential responses of the growth hormone axis in two rat models of streptozotocin-induced insulinopenic diabetes.
    Kim E; Sohn S; Lee M; Jung J; Kineman RD; Park S
    J Endocrinol; 2006 Feb; 188(2):263-70. PubMed ID: 16461552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoleptinemia, but not hypoinsulinemia, induces hyperphagia in streptozotocin-induced diabetic rats.
    Hidaka S; Yoshimatsu H; Kondou S; Oka K; Tsuruta Y; Sakino H; Itateyama E; Noguchi H; Himeno K; Okamoto K; Teshima Y; Okeda T; Sakata T
    J Neurochem; 2001 May; 77(4):993-1000. PubMed ID: 11359864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of uncontrolled diabetes on plasma ghrelin concentrations and ghrelin-induced feeding.
    Gelling RW; Overduin J; Morrison CD; Morton GJ; Frayo RS; Cummings DE; Schwartz MW
    Endocrinology; 2004 Oct; 145(10):4575-82. PubMed ID: 15256489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of methamphetamine on expression of neuropeptide Y mRNA in hypothalamus and on serum leptin and ghrelin concentrations in ad libitum-fed and schedule-fed rats.
    Crowley WR; Ramoz G; Keefe KA; Torto R; Kalra SP; Hanson GR
    Neuroscience; 2005; 132(1):167-73. PubMed ID: 15780475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetic hyperphagia--ghrelin in the driver's seat.
    Gelling RW
    Endocrinology; 2006 Jun; 147(6):2631-3. PubMed ID: 16707731
    [No Abstract]   [Full Text] [Related]  

  • 12. Agouti-related protein is a mediator of diabetic hyperphagia.
    Qu SY; Yang YK; Li JY; Zeng Q; Gantz I
    Regul Pept; 2001 Apr; 98(1-2):69-75. PubMed ID: 11179781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased hypothalamic content of preproneuropeptide-Y messenger ribonucleic acid in streptozotocin-diabetic rats.
    White JD; Olchovsky D; Kershaw M; Berelowitz M
    Endocrinology; 1990 Feb; 126(2):765-72. PubMed ID: 2404748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severity of the catabolic condition differentially modulates hypothalamic expression of growth hormone-releasing hormone in the fasted mouse: potential role of neuropeptide Y and corticotropin-releasing hormone.
    Luque RM; Park S; Kineman RD
    Endocrinology; 2007 Jan; 148(1):300-9. PubMed ID: 17038558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway.
    Shintani M; Ogawa Y; Ebihara K; Aizawa-Abe M; Miyanaga F; Takaya K; Hayashi T; Inoue G; Hosoda K; Kojima M; Kangawa K; Nakao K
    Diabetes; 2001 Feb; 50(2):227-32. PubMed ID: 11272130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of neuropeptide Y and its mRNA in STZ-diabetic rats.
    Fu M; Li X; Zhang M; Xian Y
    Chin Med J (Engl); 2002 May; 115(5):690-5. PubMed ID: 12133536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropeptide Y release from the paraventricular nucleus increases in association with hyperphagia in streptozotocin-induced diabetic rats.
    Sahu A; Sninsky CA; Phelps CP; Dube MG; Kalra PS; Kalra SP
    Endocrinology; 1992 Dec; 131(6):2979-85. PubMed ID: 1446635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of intracerebroventricular insulin infusion on diabetic hyperphagia and hypothalamic neuropeptide gene expression.
    Sipols AJ; Baskin DG; Schwartz MW
    Diabetes; 1995 Feb; 44(2):147-51. PubMed ID: 7859932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous ghrelin regulates episodic growth hormone (GH) secretion by amplifying GH Pulse amplitude: evidence from antagonism of the GH secretagogue-R1a receptor.
    Zizzari P; Halem H; Taylor J; Dong JZ; Datta R; Culler MD; Epelbaum J; Bluet-Pajot MT
    Endocrinology; 2005 Sep; 146(9):3836-42. PubMed ID: 15919752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low plasma leptin levels contribute to diabetic hyperphagia in rats.
    Sindelar DK; Havel PJ; Seeley RJ; Wilkinson CW; Woods SC; Schwartz MW
    Diabetes; 1999 Jun; 48(6):1275-80. PubMed ID: 10342816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.